Unlock Hyper-Personalization: Closing the Gapby Lilu Anderson 29.03.2024Closing the gap with big U.S. companies like Amazon and Netflix requires the right data architecture and lightning-fast app performance ...
Reddit Shares Plunge 25%, Finish Week Below Opening Priceby Mark Eisenberg 29.03.2024Shares of Reddit closed below their first-day trading price, ending the week at $49.32. They started strong, soaring 30% on ...
Fairfax County Expands Court Access with Remote Kiosksby Lilu Anderson 29.03.2024The AI program in the county won't generate its own answers. They are also reaching out to nonprofits for kiosk ...
Moleculin Biotech Stock Coverage and Analysis at StockNewsby Mark Eisenberg 28.03.2024Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
Moleculin Biotech Stock Receives “Sell” Rating – Analystsby Mark Eisenberg 28.03.2024Atticus Wealth Management LLC buys stake in Moleculin Biotech as the firm sets a “sell” rating on the stock; MBRX ...
Gap Inc. Executive Sells $260k+ in Company Stockby Terry Bingman 28.03.2024Gap Inc's Chief Legal & Compliance Officer, Julie Gruber, has sold 9,414 shares of common stock. Gruber now holds 1,384 ...
Best Bank Apps for Secure Bankingby Mark Eisenberg 28.03.2024Consumer Reports found that three out of four Americans use banking apps, but it's crucial to choose a secure app. ...
David Gardner: The Challenges of Angel Investing | WRAL TechWireby Mark Eisenberg 28.03.2024Angel investing can be difficult yet rewarding. Angels learn a lot and enjoy their involvement. Despite challenges, it is an ...
New AI Benchmark Tests Speed of Responses – Arizona Digital Free Pressby Lilu Anderson 28.03.2024MLCommons has introduced two new benchmarks to measure the speed of AI chips and systems in generating responses from data-packed ...
NextCure, Inc.: Promising Growth Potential or Risky Investment?by Mark Eisenberg 28.03.2024NextCure, Inc. (NXTC) is a biopharmaceutical company focused on novel immunomedicines. Strong financials, positive outlook, and promising pipeline.